References
- Ahn, J. K., Moon, H. J. (2009). Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration. Amer. J. Ophthalmol., 148, 718–724.10.1016/j.ajo.2009.06.01219674731
- Anonymous (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89–95.
- Askou, A. L., Alsing, S., Benckendorff, J. N. E., Holmgaard, A., Mikkelsen, J. G., Aagaard, L., Bek, T., Corydon, T. J. (2019). Suppression of choroidal neovascularization by AAV-based dual-acting antiangiogenic gene therapy. Mol. Ther. Nucl. Acids, 16, 38–50.10.1016/j.omtn.2019.01.012639370730825671
- Bai, Y., Liang, S., Yu, W., Zhao, M., Huang, L., Zhao, M., Li, X. (2014). Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta. Mol. Vision, 20, 1258–1270.
- Bakri, N. M., Ramachandran, V., Kee, H. F., Subrayan, V., Isa, H., Ngah, N. F., Mohamad, N. A., Mooi, C. S., Mun, C. Y., Ismail, P., Ismail, F., Sukiman, E. S., Sulaiman, W. A. W. (2018). Copy number variation in VEGF gene as a biomarker of susceptibility to age-related macular degeneration. Egypt. J. Med. Hum. Gen.,19, 207–213.10.1016/j.ejmhg.2017.09.003
- Balne, P. K., Agrawal, R., Bijin, V., Lee, B., Ghosh, A., Sethy, S., Agrawal, M., Narayanan, R., Connolly, J. (2018). Dataset of plasma and aqueous humor cytokine profiles in patients with exudative age related macular degeneration and polypoidal choroidal vasculopathy. Data in Brief, 19, 1570–1573.10.1016/j.dib.2018.05.085614176530246075
- Berg, K., Pedersen, T. R., Sandvik, L., Bragadottir, R. (2015). Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS tret-and-extend protocol. Ophthalmology, 122, 146–152.10.1016/j.ophtha.2014.07.04125227499
- Betsholtz, C. (2004). Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev.,15, 215–228.10.1016/j.cytogfr.2004.03.00515207813
- Bhutto, I. A., McLeod, D. S., Hasegawa, T., Kim, S. Y., Merges, C., Tong, P., Lutty, G. A. (2006). Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp. Eye Res., 82 (1), 99–110.10.1016/j.exer.2005.05.007493284716019000
- Cabral, T., Lima, L. H., Mello, L. G. M., Polido, J., Correa, E. P., Oshima, A., Duong, J., Serracarbassa, P., Regatieri, C. V., Mahajan, V. B., Belfort, R. J. (2018). Bevacizumab injection in patients with neovascular age-related macular degeneration increases angiogenic biomarkers. Ophthalm. Retina, 2 (1), 31–37.10.1016/j.oret.2017.04.004578331429376143
- Castellino, N., Longo, A., Avitabile, T., Russo, A., Fallico, M., Bonfiglio, V., Toro, M. D., Rejdak, R., Nowomiejska, K., Murabito, P., Furino, C., Reibaldi, M. (2018). Circulating insulin-like growth factor-1: A new clue in the pathogenesis of age-related macular degeneration. Aging, 10 (12), 4241–4247.10.18632/aging.101727632664830594908
- Chakravarthy, U., Bailey, C., Brown, D., Campochiaro, P., Chittum, M., Csaky, K., Tufail, A., Yates, P., Cech, P., Giraudon, M., Delmar, P., Szczesny, P., Sahni, J., Boulay, A., Nagel, S., Fürst-Recktenwald, S., Schwab, D. (2017). Phase I trial of anti-vascular endothelial growth factor/anti-angiopoietin 2 bispecific antibody RG7716 for neovascular age-related macular degeneration. Ophthalmol. Retina, 1, 474–485.10.1016/j.oret.2017.03.00331047438
- Chen, L. J., Ma, L., Chu, W. K., Lai, T. Y. Y., Chen, H., Brelen, M. E., Rong, S. S., Young, A. L., Tam, P. O. S., Zhang, M., Pang, C. P. (2016). Identification of PGF as a new gene for neovascular age-related macular degeneration in a Chinese population. Invest. Ophthalmol. Vis. Sci.,57, 1714–1720.10.1167/iovs.IOVS-15-1867727064391
- Chiu, C. J., Conley, Y. P., Gorin, M. B., Gensler, G., Lai, C. Q., Shang, F., Taylor, A. (2011). Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 52, 9099–9107.10.1167/iovs.11-7782323196722058336
- Clemons, T. E., Milton, R. C., Klein, R., Seddon, J. M., Ferris, 3rd F. L. (2005). Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS). AREDS report No. 19. Ophthalmology,112, 533–539.
- Clijn, J. M., Buitendijk, G. H. S., Prokofyeva, E., Alves, D., Cachulo, M. L., Khawaja, A. P., Cougnard-Gregoire, A., Merle, B. M. J., Korb, C., Erke, M. G. et al. (2017). Prevalence of age-related macular degeneration in Europe. Ophthalmology, 124 (12), 1753–1763.10.1016/j.ophtha.2017.05.035575546628712657
- Evans, J. R., Fletcher, A. E., Wormald, R. P. (2004). Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: An add-on study to the medical research council trial of assessment and management of older people in the community. Ophthalmology, 111, 513–517.10.1016/j.ophtha.2003.07.01215019328
- Fallah, A., Sadeghinia, A., Kahroba, H., Samadi, A., Heidari, H. R., Bradaran, B., Zeinali, S., Molavi, O. (2019). Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases. Biomed. Pharmacother.,110, 775–785.10.1016/j.biopha.2018.12.02230554116
- Farnoodian, M., Wang, S., Dietz, J., Nickells, R. W., Sorenson, C. M., Sheibani, N. (2017). Negative regulators of angiogenesis: Important targets for treatment of exudative AMD. Clin. Sci. (Lond), 131 (15), 1763–1780.10.1042/CS20170066601684728679845
- Garcia-Garcia, L., Recalde, S., Hernandez, M., Bezunartea, J., Rodriguez-Madoz, J. R., Johnen, S., Diarra, S., Marie, C., Izsvak, Z., Ivics, Z. et al. (2017). Long-term PEDF release in rat iris and retinal epithelial cells after sleeping beauty transposon-mediated gene delivery. Mol. Ther. Nucl. Acids, 9, 1–11.10.1016/j.omtn.2017.08.001558339529246287
- Grassmann, F., Friedrich, U., Fauser, S., Schick, T., Milenkovic, A., Schulz, H. L., von Strachqitz, C. N., Bettecken, T., Lichtner, P., Meitinger, T., Arend, N., Wolf, A., Haritoglou, C., Rudolph, G., Chakravarthy, U. (2015). A candidate gene association study identifies DAPL1 as a female-specific susceptibility locus for age-related macular degeneration (AMD). NeuroMol. Med.,17 (2), 111–120.10.1007/s12017-015-8342-1441916225680934
- Gu, X., Yu, X., Dai, H. (2014). Intravitreal injection of ranibizumab for treatment of age-related macular degeneration: Effects on serum VEGF concentration. Curr. Eye Res.,39 (5), 518–521.10.3109/02713683.2013.84889924215127
- Gupta, D., Gupta, V., Singh, V., Chawla, S., Parveen, F., Agrawal, S., Phadke, S. R. (2014). Study of polymorphisms in CX3CR1, PLEKHA1 and VEGF genes as risk factors for age-related macular degeneration in Indian patients. Arch. Med. Res.,45, 489–494.10.1016/j.arcmed.2014.07.00525050486
- Huber, M., Wachtlin, J. (2012). Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization. Ophthalmologica, 228, 188–193.10.1159/00033995222868384
- Huo, X., Li, Y., Jiang, Y., Sun, X., Gu, L., Guo, W., Sun, D. (2015). Inhibition of ocular neovascularization by co-inhibition of VEGF-A and PLGF. Cell Physiol. Biochem., 35, 1787–1796.10.1159/00037399025832861
- Jaffe, G. J., Ciulla, T. A., Ciardella, A. P., Devin, F., Dugel, P. U., Eandi, C. M., Masonson, H., Mones, J., Pearlman, J. A., Quaranta-El Maftouhi, M., Ricci, F., Westby, K., Patel, S. C. (2017). Dual antagonism of PDGF and VEGF in neovascular age-related macular degeneration. Ophthalmology,124, 224–234.10.1016/j.ophtha.2016.10.01028029445
- Kazlauskas, A. (2017). PDGFs and their receptors. Gene, 614, 1–7.10.1016/j.gene.2017.03.003672814128267575
- Kersten, E., Paun, C. C., Schellevis, R. L., Hoyng, C. B., Delcourt, C., Lengyel, I., Peto, T., Ueffing, M., Klaver, C. C. W., Dammeier, S., den Hollander, A. I., de Jong, E. K. (2018). Systemic and ocular fluid compunds as potential biomarkers in age-related macular degeneration. Surv. Ophthalmol., 63, 9–39.10.1016/j.survophthal.2017.05.00328522341
- Kim, J., Park, J. R., Choi, J., Park, I., Hwang, Y., Bae, H., Kim, Y., Choi, W., Yang, J. M., Han, S. et al. (2019). Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration. Sci. Adv.,5, eaau6732.
- Kinnunen, K., Petrovski, G., Moe, M. C., Berta, A., Kaarniranta, K. (2012). Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol.,90, 299–309.10.1111/j.1755-3768.2011.02179.x22112056
- Lambert, N. C., El Shelmani, H., Singh, M. K., Mansergh, F. C., Wride, M. A., Padilla, M., Keegan, D., Hogg, R. E., Ambati, B. K. (2016). Risk factors and biomarkers of age-related macular degeneration. Progr. Retinal Eye Res.,54, 64–102.10.1016/j.preteyeres.2016.04.003499263027156982
- Lambert, N. G., Zhang, X., Rai, R. R., Uehara, H., Choi, S., Carroll, L. S., Das, S. K., Cahoon, J. M., Kirk, B. H., Bentley, B. M., Ambati, B. K. (2016). Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration. Exper. Eye Rese., 145, 248–257.10.1016/j.exer.2016.01.009586203826775053
- Li, R., Du, J. H., Yao, G. M., Yao, Y., Zhang, J. (2019). Autophagy: A new mechanism for regulating VEGF and PEDF expression in retinal pigment epithelium cells. Int. J. Ophthalmol., 12 (4), 557–562.
- Masli, S., Sheibani, N., Cursiefen, C., Zieske, J. (2014). Matricellular protein thrombospondin: Influence on ocular angiogenesis, wound healing and immuneregulation. Curr. Eye Res.,39 (8), 759–774.10.3109/02713683.2013.877936427864724559320
- Mesquita, J., Castro-de-Sousa, J. P., Vaz-Pereira, S., Neves, A., Passarinha, L. A., Tomaz, C. T. (2018). Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives. Cytokine Growth Factor Rev., 39, 102–115.10.1016/j.cytogfr.2017.11.00529248329
- Mitchell, P., Liew, G., Gopinath, B., Wong, T. Y. (2018). Age-related macular degeneration. Lancet, 392, 1147–1159.10.1016/S0140-6736(18)31550-2
- Ng, D. S., Yip, Y. W., Bakthavatsalam, M., Chen, L. J., Ng, T. K., Lai, T. Y., Pang, C. P., Brelen, M. E. (2017). Elevated angiopoietin 2 in aqueous of patients with neovascular age related macular degeneration correlates with disease severity at presentation. Sci. Rep., 27 (7), 45081.
- Ng, E. W. M., Adamis, A. P. (2005). Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can. J. Ophthalmol., 40, 352–368.10.1016/S0008-4182(05)80078-X
- Owen, C. G., Jarrar, Z., Wormald, R., Cook, D. G., Fletcher, A. E., Rudnicka, A. R. (2012). The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Brit. J. Ophthalmol., 96, 752–756.10.1136/bjophthalmol-2011-301109332963322329913
- Rakic, J. M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J. M., Noël, A., Munaut, C. (2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci., 44, 3186–3193.10.1167/iovs.02-109212824270
- Rastogi, N., Smith, T. (2016). Association of age-related macular degeneration and reticular macular disease with cardiovascular disease. Surv. Ophthalmol., 61 (4), 422–433.10.1016/j.survophthal.2015.10.00326518628
- Rein, D. B., Wittenborn, J. S., Zhang, X., Honeycutt, A. A., Lesesne, S. B., Saaddine, J. (2009). Vision health cost-effectiveness study group. Forecasting age-related macular degeneration through the year 2050. Arch. Ophthalmol., 127 (4), 533–540.
- Rosenthal, R., Wohlleben, H., Malek, G., Schlichting, L., Thieme, H., Bowes Rickman, C., Strauss, O. (2004). Insulin-like growth factor-1 contributes to neovascularization in age-related macular degeneration. Biochem. Biophys. Res. Commun., 323, 1203–1208.10.1016/j.bbrc.2004.08.21915451424
- Sall, J. W., Klisovic, D. D., O’Dorisio, M. S., Katz, S. E. (2004). Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells. Exper. Eye Res.,79 (4), 465–476.10.1016/j.exer.2004.06.00715381031
- Storkebaum, E., Carmeliet, P. (2004). VEGF: A critical player in neurodegeneration. J. Clin. Invest., 113 (1), 14–18.10.1172/JCI2068230088814702101
- Tamhane, M., Cabrera-Ghayouri, S., Abelian, G., Viswanath, V. (2019). Review of biomarkers in ocular matrices: Challenges and opportunities. Pharm. Res., 36, 40.10.1007/s11095-019-2569-8634439830673862
- Tong, J. P., Chan, W. M., Liu, D. T. L., Lai, T. Y. Y., Choy, K. W., Pang, C. P., Lam, D. S. C. (2006). Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Amer. J. Ophthalmol., 141, 456–462.10.1016/j.ajo.2005.10.01216490490
- Tosi, G. M., Orlandini, M., Galvagni, F. (2018). The controversial role of TGF-ß in neovascular age-related macular degeneration pathogenesis. Int. J. Mol. Sci.,19, 3363.
- Tsai, D. C., Charng, M. J., Lee, F. L., Hsu, W. M., Chen, S. J. (2006). Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica, 220 (4), 246–251.10.1159/000093079
- Van Bergen, T., Etienne, I., Cunningham, F., Moons, L., Schlingemann, R. O., Feyen, J. H. M., Stitt, A. W. (2019). The role of placental growth factor (PIGF) and its receptor system in retinal vascular diseases. Progr. Retinal Eye Res., 69, 116–136.10.1016/j.preteyeres.2018.10.006
- van Lookeren Campagne, M., LeCouter, J., Yaspan, B. L., Ye, W. (2014). Mechanisms of age-related macular degeneration and therapeutic opportunities. J. Pathol., 232, 151–164.10.1002/path.4266
- Wong, W. L., Su, X., Li, X., Cheung, C. M., Klein, R., Cheng, C. Y., Wong, T. Y. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Heal, 2, e106–e115.10.1016/S2214-109X(13)70145-1
- Zarranz-Ventura, J., Fernandez-Robredo, P., Recalde, S., Salinas-Alaman, A., Borras-Cuesta, F., Dotor, J., Garcia-Layana, A. (2013). Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides. PLoS ONE, 8 (5), e65434.10.1371/journal.pone.0065434366924923741494
- Zehetner, C., Kirchmair, R., Neururer, S. B., Kralinger, M. T., Bechrakis, N. E., Kieselbach, G. F. (2014). Systemic upregulation of PDGF-B in patients with neovascular AMD. Invest. Ophthalmol. Vis. Sci., 55, 337–344.10.1167/iovs.13-1297824334449